Business Trends

Mar 27, 2018
By BioPharm International Editors
In a $13-billion transaction, GSK will purchase Novartis’ share of the Consumer Healthcare Joint Venture.
Mar 19, 2018
By BioPharm International Editors
The companies intend to jointly develop and commercialize Lenvima (lenvatinib mesylate) as a monotherapy and an in-combination therapy for treating multiple cancer types.
Mar 15, 2018
BioPharm International
A different perspective on controlling fixed costs of biomanufacturing, based on know-how from other industries, provides a competitive edge, says the CEO of Samsung BioLogics.
Mar 06, 2018
By BioPharm International Editors
The pharma major will spin out six molecules in early stage inflammation and autoimmune programs into a new company called Viela Bio.
Feb 05, 2018
New programs and initiatives by industry examine rising healthcare costs.
Feb 02, 2018
By BioPharm International Editors
The NECC supervisory pharmacist at the center of the 2012 fungal meningitis outbreak was sentenced to 8 years in prison.
Feb 01, 2018
BioPharm International
Frustrated with high costs and drug shortages, hospitals adopt a DIY approach.
Jan 23, 2018
By BioPharm International Editors
The latest continuing resolution funds the government for three weeks.
Jan 22, 2018
By BioPharm International Editors
Non-essential activities and new regulatory submissions are on hold until a federal government funding agreement is reached.
Jan 19, 2018
By BioPharm International Editors
Frustrated with chronic shortages and high costs, hospitals form their own generic drug company.
native1_300x100
lorem ipsum